Value and Risk in Pharma and Biotech

Avance, Basel GmbH
Lautengartenstrasse 7
4052 Basel

Auf Karte anzeigen
Firmenbeschrieb
Avance is specialized in valuation and risk management in pharma and biotech. Avance offers consulting and software solutions for biotech and pharma as well as VCs, funds and financial institutions.

Gründungsjahr
2004
 
Rechtsform
Gesellschaft mit beschränkter Haftung (GmbH)
 
Anzahl Mitarbeiter
2
 
Umsatz
Keine Angabe CHF
 
Zielmärkte
USA/Kanada, Europa
 


Unser Team

Boris Bogdan

Dr. med.

borisbogdan@avance.ch

Ralph Villiger


ralphvilliger@avance.ch
Marktleistungen
  • Consulting
    The services comprise valuation (valuation of drug development projects, pipeline valuation, company valuation, license contract valuation, liquidity simulation and planning), risk management (design and implementation of company wide risk management , pipeline asset and liability management, decision support for strategic capital allocation, hedging strategies), and development of financial strategies. Avance also conceives tailormade software solutions and holds training programs on valuation and risk management.
  • RIVAL
    Rival is a sophisticated valuation and risk management tool for the biopharmaceutical sector. It offers valuation and risk assessment for drug development projects, pipelines and license contracts. Rival is designed to meet the requirements of in-house project funding, project and pipeline management, license contract negotiation, company valuation.
Kernkompetenzen
  • Innovationskraft in der Entwicklung neuer Lösungen und Produkte
  • Schnelligkeit in der Auftragsabwicklung
  • Massgeschneiderte Kundenlösungen
Kundengruppen
  • Pharma
  • Biotech
  • Banks
  • Funds
Eintrag erstellt: 05.02.2005, Letzte Änderung: 05.02.2005